Bank of Montreal’s Immune Design Corp. IMDZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-446
Closed -$1K 5125
2018
Q4
$1K Buy
446
+215
+93% +$374 ﹤0.01% 4640
2018
Q3
$1K Sell
231
-7
-3% -$26 ﹤0.01% 4700
2018
Q2
$1K Buy
+238
New +$948 ﹤0.01% 4684
2016
Q2
Sell
-25
Closed 4621
2016
Q1
$0 Hold
25
﹤0.01% 4667
2015
Q4
$1K Hold
25
﹤0.01% 4181
2015
Q3
$0 Hold
25
﹤0.01% 4392
2015
Q2
$1K Hold
25
﹤0.01% 3913
2015
Q1
$1K Buy
+25
New +$652 ﹤0.01% 3944

Other funds holding IMDZ

Bank of Montreal's IMDZ Position: Q1 2019 in Review

Bank of Montreal sold out of Immune Design Corp. (IMDZ) in Q1 2019, closing a stake of 446 shares — an estimated $1K sold.

Bank of Montreal first reported a position in IMDZ in Q1 2015 and held it in 8 quarters. The position peaked at $1K in Q4 2018. 68 funds tracked by Wall St. Rank hold IMDZ as of Q1 2019.

  • Bank of Montreal reported no remaining Immune Design Corp. position as of Q1 2019 after selling out during the quarter.
  • Bank of Montreal sold 446 Immune Design Corp. shares in Q1 2019, an estimated $1K.
  • Bank of Montreal first reported a position in Immune Design Corp. in Q1 2015 and held it in 8 quarters.
  • Bank of Montreal's Immune Design Corp. position peaked at $1K in Q4 2018.
  • 68 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2019.

Based on Bank of Montreal's 13F filing for Q1 2019, filed 26 Apr 2019.